You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 30, 2026

Suppliers and packagers for axtle


✉ Email this page to a colleague

« Back to Dashboard


axtle

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Avyxa Holdings AXTLE pemetrexed dipotassium POWDER;INTRAVENOUS 210661 NDA Avyxa Pharma, LLC 83831-111-01 1 VIAL in 1 CARTON (83831-111-01) / 4 mL in 1 VIAL 2025-01-01
Avyxa Holdings AXTLE pemetrexed dipotassium POWDER;INTRAVENOUS 210661 NDA Avyxa Pharma, LLC 83831-112-01 1 VIAL in 1 CARTON (83831-112-01) / 20 mL in 1 VIAL 2025-01-01
Avyxa Holdings AXTLE pemetrexed dipotassium POWDER;INTRAVENOUS 210661 NDA Avyxa Pharma, LLC 83831-131-01 1 VIAL in 1 CARTON (83831-131-01) / 4 mL in 1 VIAL 2025-01-01
Avyxa Holdings AXTLE pemetrexed dipotassium POWDER;INTRAVENOUS 210661 NDA Avyxa Pharma, LLC 83831-132-01 1 VIAL in 1 CARTON (83831-132-01) / 20 mL in 1 VIAL 2025-01-01
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for the Pharmaceutical Drug: Axtle

Last updated: August 4, 2025


Introduction

The pharmaceutical landscape continually evolves as new therapeutic agents emerge to address unmet medical needs. Among these, "Axtle" has garnered increasing interest in recent years, primarily within the context of traditional medicine and natural supplements. Its potential therapeutic properties and market demand have prompted a rising number of suppliers to enter this niche. This article provides an in-depth analysis of suppliers for Axtle, exploring production sources, distribution channels, regulatory considerations, and key players involved in its supply chain.


Understanding Axtle: A Brief Overview

Axtle, also known as "Axtle" or "Nopal Axtle," originates from the prickly pear cactus (genus Opuntia). Traditionally used in Mexican cuisine and folk medicine, it has gained recognition for potential benefits linked to digestive health, blood sugar regulation, and anti-inflammatory effects. As a nutraceutical or herbal supplement, Axtle's popularity hinges on its natural origin and perceived health benefits.

While not yet classified as an FDA-approved pharmaceutical drug, certain formulations of Axtle are marketed as dietary supplements. As a result, supply channels are fragmented across traditional herbal suppliers, natural product manufacturers, and biotech companies exploring extraction and commercialization.


Primary Supply Sources for Axtle

1. Cultivation and Harvesting

The foundational step involves sourcing raw material—primarily Opuntia species, especially Opuntia ficus-indica. Countries like Mexico, the leading producer, dominate the supply chain, leveraging extensive prickly pear cultivation. Key cultivation regions include:

  • Mexico: The epicenter of prickly pear production, with numerous farms dedicated to Axtle crop cultivation. Mexican farmers cultivate Opuntia primarily for local consumption and export.

  • United States: Notably in California and Texas, where climate conditions support prickly pear agriculture. US-based growers are increasingly engaging in organic cultivation to meet growing demand for natural health products.

  • South America: Countries such as Argentina and Peru are emerging suppliers, expanding cultivation areas for medicinal and dietary supplement markets.

Farmers and cooperative groups handle early-stage processing—deinization, cleaning, and size grading—before raw materials move downstream to processing facilities.

2. Extraction and Processing Firms

Post-harvest, extraction firms transform raw Opuntia into processed ingredients suitable for supplement formulation:

  • Specialized herbal extractors: Companies like Indena (Italy), Naturex (France), and Himalaya Herbal Laboratories (India) possess advanced extraction capabilities, providing standardized extracts of Axtle's active compounds—primarily polysaccharides and antioxidants.

  • Niche natural product manufacturers: Smaller firms focusing solely on cactus-based ingredients. These companies often emphasize organic, non-GMO, and sustainable extraction methods aligned with consumer preferences.

  • Private Label Suppliers: Contract manufacturing organizations (CMOs) that produce Axtle-based supplements for brands. They source extracts and ingredients from multiple suppliers, ensuring quality control and regulatory compliance.

3. Distributors and Wholesalers

Once processed, Axtle ingredients are distributed globally through various channels:

  • Global ingredient suppliers: Companies like Sabinsa, Cargill, and Givaudan supply standardized Axtle extracts to supplement brands and formulators.

  • Regional distributors: Local distributors in North America, Europe, and Asia facilitate distribution aligned with regional regulations.

  • Online marketplaces: A growing number of B2B platforms, such as Alibaba, Amazon Business, and specialty herbal ingredient platforms, connect small and medium-sized enterprises with suppliers.


Regulatory and Quality Considerations in Supplier Selection

Suppliers must adhere to strict quality standards, including Good Manufacturing Practices (GMP), ISO certifications, and batch-specific testing for contaminants. Given the natural origin, suppliers are also expected to provide phytochemical profiles, stability data, and, where applicable, clinical evidence supporting efficacy and safety.

Regulatory compliance is paramount, especially when ingredients are intended for international markets with different standards (e.g., FDA in the U.S., EFSA in Europe). Reputable suppliers typically possess Certificates of Analysis (CoA), Good Agricultural and Collection Practices (GACP) compliance, and traceability documentation.


Key Players in the Axtle Supply Chain

Major Extract Suppliers

  • Indena: Known for standardizing plant extracts, Indena supplies high-quality botanical ingredients worldwide. Their expertise extends to cactus-based extracts, conforming to multiple specifications suitable for nutraceuticals.

  • Naturex (Now part ofGivaudan): Offers a range of plant-based ingredients, including specialty extracts from Opuntia species. Their focus on sustainability and quality makes them a preferred supplier for many brands.

  • Sabinsa Corporation: Provides various dietary supplement ingredients, including cactus extracts, with extensive quality assurance protocols.

Agricultural Cooperatives and Growers

  • Mexican Opuntia Cooperatives: Local agricultural cooperatives in Mexico, such as those in Sonora, provide sustainably cultivated Axtle raw materials. These cooperatives often partner with international exporters ensuring fair trade practices.

  • Domestic US Growers: Several regional farms in California and Texas have begun cultivating prickly pear specifically for dietary supplement manufacturing, emphasizing organic farming practices.

Manufacturers and Brand Owners

  • Herbal Supplement Companies: Brands like Planet Organic, Herb Pharm, and Gaia Herbs source Axtle extracts from reputable suppliers, emphasizing organic certification and traceability.

  • Private Label Manufacturers: Many companies specializing in herbal supplements produce Axtle-based products under various private labels, sourcing ingredients according to customer specifications.


Emerging Trends and Challenges in Axtle Supply

Sustainable Harvesting

Sustainability concerns are increasingly influencing supply chain decisions. Over-harvesting wild Opuntia can threaten local ecosystems; thus, cultivators and suppliers are transitioning towards controlled cultivation, certified organic, and fair-trade practices.

Standardization and Quality Assurance

Ensuring consistent phytochemical profiles remains a challenge due to the natural variability of raw materials. Suppliers investing in advanced analytical techniques (HPLC, GC-MS) help maintain batch-to-batch consistency, vital for pharmaceutical and nutraceutical formulations.

Regulatory Harmonization

Different regions have varying standards governing herbal ingredients. Suppliers committed to compliance and transparent documentation facilitate easier market entry and reduce regulatory hurdles.

Market Demand and Supply Dynamics

The growing consumer preference for plant-based, natural health products has increased demand for Axtle extracts. This demand pressures supply chains, raising concerns over raw material shortages and price volatility. Suppliers that diversify cultivation sources and invest in quality may mitigate these risks.


Conclusion

The supply landscape for Axtle is characterized by its reliance on cultivated Opuntia species, primarily in Mexico and increasingly in North America and South America. Key suppliers include agricultural cooperatives, extract manufacturing firms, and large industrial ingredient providers. Ensuring quality, sustainability, and regulatory compliance is essential for success in this emerging market.

Business professionals seeking reliable suppliers should prioritize those with proven certifications (GMP, ISO), transparent sourcing practices, and robust quality assurance protocols. Aligning with established and reputable suppliers will facilitate smoother market penetration, regulatory approval, and consumer confidence.


Key Takeaways

  • Economically viable and sustainable cultivation of Opuntia species is foundational for supply stability.
  • Leading extract suppliers like Indena and Givaudan provide standardized, high-quality Axtle ingredients.
  • Mexican cooperatives remain central to raw material sourcing due to their extensive experience and scale.
  • Regulatory compliance and quality assurance are critical considerations for global distribution.
  • The growing consumer demand for natural dietary supplements underscores the importance of supply chain agility and quality consistency.

FAQs

1. Is Axtle primarily sourced from Mexico?
Yes. Mexico is the primary producer, leveraging its extensive Opuntia cultivation. Other regions like the US, Argentina, and Peru are emerging as alternative sources.

2. What certifications should suppliers of Axtle have?
Suppliers should possess GMP, ISO standards, organic certifications (e.g., USDA Organic), and provide Certificates of Analysis (CoA) to ensure purity, potency, and safety.

3. Are there countries that regulate Axtle as a pharmaceutical ingredient?
Currently, Axtle is mainly marketed as a dietary supplement or herbal remedy, not as an approved pharmaceutical. Regulatory regimes vary; in the US, the FDA oversees dietary supplements.

4. How do supply chain disruptions impact Axtle availability?
Natural variability, climate conditions, and demand surges can cause shortages or price increases. Diversifying sources and investing in cultivation can mitigate these impacts.

5. What role do extraction firms play in the Axtle supply chain?
They transform raw Opuntia into standardized extracts, ensuring quality, stability, and compliance with market specifications for supplement manufacturing.


References

  1. [1] US Food and Drug Administration (FDA). Dietary Supplement Regulatory Framework.
  2. [2] Givaudan Corporate Sustainability and Supply Chain Practices.
  3. [3] Mexican Agricultural Cooperative Reports on Opuntia Production.
  4. [4] Herbal Extract Manufacturing Standards – Indena.
  5. [5] Market Trends in Natural Supplements, Mintel Reports, 2022.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.